Immutep Ltd (PRRUF)
OTHER OTC:PRRUF
Holding PRRUF?
Track your performance easily

Immutep Ltd (PRRUF) Similar Stocks

17 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immutep
$281.17M
-8.44
3.33%
3 Buy
0 Hold
0 Sell
Strong Buy
Bristol-Myers Squibb
$102.27B
-15.48
-13.78%
4 Buy
9 Hold
2 Sell
Hold
Merck & Company
$317.26B
139.44
22.16%
14 Buy
2 Hold
0 Sell
Strong Buy
GlaxoSmithKline
$81.50B
14.32
15.37%
3 Buy
2 Hold
0 Sell
Moderate Buy
Immutep Ltd
$281.17M
-8.60
22.22%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IMMP
Immutep
2.17
0.29
15.43%
BMY
Bristol-Myers Squibb
50.45
-7.94
-13.60%
MRK
Merck & Company
125.26
18.65
17.49%
GSK
GlaxoSmithKline
39.86
6.34
18.91%
PRRUF
Immutep Ltd
0.22
0.05
29.41%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis